Opioid Harm Reduction Strategies: Focus on Expanded Access to Intranasal Naloxone

Authors

  • Daniel P. Wermeling Pharm.D., FCCP, FASHP

    Corresponding author
    1. Department of Pharmacy Practice and Science, University of Kentucky College of Pharmacy, Lexington, Kentucky
    • Department of Pharmacy Practice and Science, University of Kentucky College of Pharmacy, 789 South Limestone Street, Lexington, KY 40536; e-mail: dwermel@uky.edu

    Search for more papers by this author

Ancillary